BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27659228)

  • 1. Soluble CD93 Is Involved in Metabolic Dysregulation but Does Not Influence Carotid Intima-Media Thickness.
    Strawbridge RJ; Hilding A; Silveira A; Österholm C; Sennblad B; McLeod O; Tsikrika P; Foroogh F; Tremoli E; Baldassarre D; Veglia F; Rauramaa R; Smit AJ; Giral P; Kurl S; Mannarino E; Grossi E; Syvänen AC; Humphries SE; de Faire U; Östenson CG; Maegdefessel L; Hamsten A; Bäcklund A;
    Diabetes; 2016 Oct; 65(10):2888-99. PubMed ID: 27659228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and characterization of soluble CD93 released during inflammation.
    Greenlee MC; Sullivan SA; Bohlson SS
    Inflamm Res; 2009 Dec; 58(12):909-19. PubMed ID: 19603257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD93 in allergic asthma.
    Park HJ; Oh EY; Han HJ; Park KH; Jeong KY; Park JW; Lee JH
    Sci Rep; 2020 Jan; 10(1):323. PubMed ID: 31941986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis.
    Greenlee-Wacker MC; Briseño C; Galvan M; Moriel G; Velázquez P; Bohlson SS
    J Immunol; 2011 Sep; 187(6):3353-61. PubMed ID: 21849679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented production of soluble CD93 in patients with systemic sclerosis and clinical association with severity of skin sclerosis.
    Yanaba K; Asano Y; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Br J Dermatol; 2012 Sep; 167(3):542-7. PubMed ID: 22540233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD93 is an apoptotic cell opsonin recognized by α
    Blackburn JWD; Lau DHC; Liu EY; Ellins J; Vrieze AM; Pawlak EN; Dikeakos JD; Heit B
    Eur J Immunol; 2019 Apr; 49(4):600-610. PubMed ID: 30656676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Soluble CD93 in Type 2 Diabetes as a Biomarker for Diabetic Nephropathy: Integrated Results from Human and Rodent Studies.
    Lee M; Park HS; Choi MY; Kim HZ; Moon SJ; Ha JY; Choi A; Park YW; Park JS; Shin EC; Ahn CW; Kang S
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32397261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD93 induces differentiation of monocytes and enhances TLR responses.
    Jeon JW; Jung JG; Shin EC; Choi HI; Kim HY; Cho ML; Kim SW; Jang YS; Sohn MH; Moon JH; Cho YH; Hoe KL; Seo YS; Park YW
    J Immunol; 2010 Oct; 185(8):4921-7. PubMed ID: 20861352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
    Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
    Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD93 in Serum as a Marker of Allergic Inflammation.
    Park HJ; Han H; Lee SC; Son YW; Sim DW; Park KH; Park YH; Jeong KY; Park JW; Lee JH
    Yonsei Med J; 2017 May; 58(3):598-603. PubMed ID: 28332366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between CD93, C1q and GIPC in the Regulation of Pneumococcal Meningitis Inflammation.
    Qiao N; Zhang J; Zhang Y; Liu X
    Ann Clin Lab Sci; 2022 Jul; 52(4):634-641. PubMed ID: 36197773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
    Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
    Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
    Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
    J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variance and plasma concentration of CD93 is associated with cardiovascular mortality: Results from a 6.7‑year follow‑up of a healthy community‑living elderly population.
    Alehagen U; Shamoun L; Wågsäter D
    Mol Med Rep; 2020 Dec; 22(6):4629-4636. PubMed ID: 33173973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD93 levels in patients with acute myocardial infarction and its implication on clinical outcome.
    Youn JC; Yu HT; Jeon JW; Lee HS; Jang Y; Park YW; Park YB; Shin EC; Ha JW
    PLoS One; 2014; 9(5):e96538. PubMed ID: 24801400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD93 as a Novel Biomarker in Asthma Exacerbation.
    Sigari N; Jalili A; Mahdawi L; Ghaderi E; Shilan M
    Allergy Asthma Immunol Res; 2016 Sep; 8(5):461-5. PubMed ID: 27334785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA.
    Nativel B; Ramin-Mangata S; Mevizou R; Figuester A; Andries J; Iwema T; Ikewaki N; Gasque P; Viranaïcken W
    Immunology; 2019 Oct; 158(2):85-93. PubMed ID: 31335975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of serum soluble CD93 as a biomarker for asthma in an ovalbumin-induced asthma murine model.
    Park HJ; Oh EY; Park YH; Yang M; Park KH; Park JW; Lee JH
    Biomarkers; 2018 Jul; 23(5):446-452. PubMed ID: 29498549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic regulation of microglia differentiation by CD93 and integrin β1 in the rat pneumococcal meningitis model.
    Qiao N; Zhang J; Zhang Y; Liu X
    Immunol Lett; 2022 Dec; 251-252():63-74. PubMed ID: 36336138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in CD93 (C1qRp) expression in a human monocyte-like cell line (U937) treated with various apoptosis-inducing chemical substances.
    Ikewaki N; Tamauchi H; Inoko H
    Microbiol Immunol; 2007; 51(12):1189-200. PubMed ID: 18094537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.